HOME >> MEDICINE >> NEWS
ASU secures $3.9 million to study spinal cord injuries and neurological disorders

t, diagnosis and treatment of neurologically degenerative diseases such as Alzheimer's as well as traumatic brain and spinal cord injuries and stroke. A grant to purchase a state-of-the-art magnetic resonance imaging (MRI) and spectroscopy system will provide scientists an opportunity to advance basic biomedical discoveries aimed at improving human health.

The $1.3 million high-resolution, 7.0 Tesla magnetic imaging system will allow 2-D and 3-D image reconstruction. With a resolution below 100 micrometers, the system allows researchers to see tissues or structures smaller than the width of a human hair.

In addition to Jung, other team members on this project include faculty from the schools of life sciences and engineering at ASU, Eric Reiman, M.D. from Banner Good Samaritan Medical Center; Mark Preul, M.D. and Adrienne Scheck, M.D., Barrows Neurological Institute.

Adaptive Electrical Stimulation for Locomotor Retraining

Recent studies indicate that individuals with spinal cord injury may be able to enhance their functional recovery of movement by performing repetitive stepping movements. Currently, individuals perform this therapy on a treadmill supported by a harness and passive assistance provided by therapists. The repetition is believed to help the body to re-learn how to generate suitable signals in the brain and spinal cord that will enable them to step independently.

With the $850,000 grant from NIH's National Center for Medical Rehabilitation Research, Abbas and Jung will develop a neuroprosthetic system to electrically stimulate muscles to produce repeatable stepping movements with coordinated sensory and motor patterns. By using the stimulation to contract the muscles in an orchestrated manner that mimics natural muscle movement, the team hopes to improve the therapy and reduce reliance on a supportive harness. The adaptive nature of the control mechanism puts some 'intelligence' in the system to provide
'"/>

Contact: Gretchen Dobosz
gretchen.dobosz@asu.edu
480-727-0788
Arizona State University
27-Sep-2005


Page: 1 2 3 4

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. Spinifex secures $3.25m investment to develop pain therapy
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
8. FPG receives $8 million for autism research
9. CIRM awards $3.79 million to Burnham Institute
10. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
11. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases

Post Your Comments:
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and ... Merchandise Show to bestow a Juvent Sports Achievement award ... Arlene McKitrick. The award commemorated and congratulated McKitrick for ... She won her first amateur tournament in 1979 and ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
Cached News: